Stoke Therapeutics
STOK
#6630
Rank
NZ$0.89 B
Marketcap
$16.37
Share price
-1.21%
Change (1 day)
-16.58%
Change (1 year)

Stoke Therapeutics (STOK) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.36 Billion

According to Stoke Therapeutics's latest financial reports the company has NZ$0.36 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Stoke Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.38 B20.77%
2023-12-31NZ$0.31 B-11.94%
2022-12-31NZ$0.36 B12.37%
2021-12-31NZ$0.32 B-19.18%
2020-12-31NZ$0.39 B20.54%
2019-12-31NZ$0.33 B110.23%
2018-12-31NZ$0.15 B6110.06%
2017-12-31NZ$2.53 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.42 B 18.01%๐Ÿ‡บ๐Ÿ‡ธ USA